Premier (PINC) Company Report

Analyst Earnings Quarterly Reports

Earnings summaries and quarterly performance for Premier.

Analyst Coverage

Research analysts who have asked questions during Premier earnings calls.

Eric Percher

Nephron Research

4 questions for PINC

Also covers: AMWL, CAH, COR +5 more

Jessica Tassan

Piper Sandler

4 questions for PINC

Also covers: ACCD, ALHC, AMWL +11 more

Kevin Caliendo

UBS

4 questions for PINC

Also covers: AHCO, ALGN, AMWL +15 more

Allen Lutz

Bank of America

3 questions for PINC

Also covers: ACCD, CAH, COR +14 more

Michael Cherny

Leerink Partners

3 questions for PINC

Also covers: ACCD, ALGN, CAH +18 more

Richard Close

Canaccord Genuity Group

3 questions for PINC

Also covers: ACCD, AHCO, CLOV +15 more

Eric Coldwell

Robert W. Baird & Co.

2 questions for PINC

Also covers: AHCO, CAH, COR +9 more

Daniel Clark

Leerink Partners

1 question for PINC

Also covers: CERT, ELAN, IDXX +3 more

Jay Lewis

Robert W. Baird & Co. Incorporated

1 question for PINC

Also covers: OMI

Stephanie Davis

Barclays

1 question for PINC

Also covers: ACCD, CAH, COR +20 more

William Sutherland

The Benchmark Company

1 question for PINC

Also covers: AMN, AONC, BEAT +10 more

Latest news

Recent press releases and 8-K filings for PINC.

Premier Development & Investment Expands Exploration Interests and Restructures Debt

PINC

New Projects/Investments

Debt Issuance

M&A

Premier Development & Investment, Inc. (PINC) has expanded its Lithium and Uranium exploration interests in Nevada with the acquisition of "Hombre" (480 acres) and "Stonewall Flat" (1,245 acres), and an additional 840 acres staked at "Hombre". All exploration properties are now 100% owned and controlled directly by Premier.
The company has restructured $2 million in PIK Notes and $6 million in Convertible Loan Notes, which were disposed of to an Investment Group and will be converted into interest-free and unsecured long-term liabilities.
Premier is increasing its holding in GNCC Capital, Inc. (GNCP) from 31% to 49% in December 2025.
Premier intends to achieve $5 million in cash during Q1 (presumably Q1 2026) through renegotiated financing arrangements and aims to increase its stock's "free float" to enhance liquidity.

Dec 16, 2025, 11:30 AM

Press Release

Premier Shareholder Vote Scheduled for November 21, 2025

PINC

M&A

Legal Proceedings

Takeover Bid

Monteverde & Associates PC is investigating the sale of Premier, Inc. (PINC) to an affiliate of Patient Square Capital.
Under the terms of the proposed transaction, Premier shareholders will receive $28.25 in cash per share.
The shareholder vote for this transaction is scheduled for November 21, 2025.

Nov 8, 2025, 1:00 AM

Press Release

Premier Biotech Acquires National Test Systems

PINC

M&A

New Projects/Investments

Revenue Acceleration/Inflection

Premier Biotech, a drug and alcohol testing solutions provider, has acquired National Test Systems (NTS), a leading provider of rapid point-of-care diagnostic drug screening supplies and services.
This acquisition is intended to accelerate Premier's growth in point-of-care drug screening services and bolster its leadership position in the drug and alcohol testing industry.
NTS serves over 1,500 facilities primarily in Government and Behavioral Health end markets, enhancing Premier's customer base.
This marks Premier's fourth acquisition since partnering with Align Capital Partners in November 2022, indicating a continued strategy of growth through M&A.

Nov 5, 2025, 1:00 PM

Press Release

Premier, Inc. Reports Q1 2026 Financial Results and Withdraws Guidance Due to Pending Acquisition

PINC

Earnings

Guidance Update

M&A

Premier, Inc. reported fiscal-year 2026 first-quarter total net revenue of $240.0 million, representing a 3% decrease from the prior-year period.
GAAP net income from continuing operations was $15.3 million, or $0.21 per diluted share, a significant decrease from the prior-year period which included a $57.0 million non-operating gain from a derivative lawsuit settlement.
Adjusted EPS was $0.30, a 12% decrease from the prior-year period, and $0.32 excluding Contigo Health, an 11% decrease.
Due to a pending acquisition by an affiliate of Patient Square Capital, Premier has withdrawn its fiscal-year 2026 guidance and suspended the declaration and distribution of common stock dividends in future quarters.
The company completed its $800.0 million share repurchase authorization by August 2025.

Nov 4, 2025, 9:31 PM

8-K

Premier Reports Fiscal-Year 2026 First-Quarter Financial Results

PINC

Earnings

Guidance Update

M&A

Premier, Inc. reported fiscal-year 2026 first-quarter total net revenue of $240.0 million, a 3% decrease from the prior-year period.
GAAP net income from continuing operations was $15.3 million, or $0.21 per fully diluted share, representing a 79% decrease from the prior-year period, primarily due to a $57.0 million non-operating gain from a derivative lawsuit settlement in the prior year.
Adjusted EBITDA was $55.0 million, a 12% decrease from the prior-year period, and adjusted EPS was $0.30.
The company has withdrawn its fiscal-year 2026 guidance due to a pending acquisition by an affiliate of Patient Square Capital, LP.

Nov 4, 2025, 11:30 AM

Press Release

Premier, Inc. to be Acquired by Patient Square Capital for $2.6 Billion

PINC

M&A

Takeover Bid

Delisting/Listing Issues

Premier, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital in a transaction valued at $2.6 billion.
Under the terms of the agreement, Premier stockholders will receive $28.25 in cash per share, which represents a 23.8% premium to Premier’s 60-day volume-weighted average price as of September 5, 2025.
The transaction is expected to close by the first quarter of calendar year 2026, subject to approval by Premier stockholders and satisfaction of regulatory approvals.
Upon completion of the transaction, Premier will become a private company, its common stock will be delisted from NASDAQ, and the declaration and distribution of common stock dividends will be suspended in future quarters.

Sep 22, 2025, 1:20 PM

8-K

Premier Inc. to be Acquired by Patient Square Capital

PINC

M&A

Takeover Bid

Delisting/Listing Issues

Premier Inc. has agreed to be acquired by an affiliate of Patient Square Capital in a deal valued at approximately $2.6 billion.
Shareholders will receive $28.25 per share in cash, which represents a 9.7% premium to the stock's recent closing price and a 23.8% premium based on a 60-day volume-weighted average price.
The acquisition is expected to close by the first quarter of 2026, at which point Premier will go private, resulting in the delisting of its shares and the suspension of future dividend payments.
Premier's Board of Directors unanimously approved the acquisition, which is not contingent upon financing arrangements but is pending stockholder and regulatory approvals.